login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ZOGENIX INC (ZGNX) Stock News
NASDAQ:ZGNX - Nasdaq -
Common Stock
26.68
+0.42 (+1.6%)
After market: 26.69
+0.01 (+0.04%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ZGNX Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Benzinga
- Mentions:
IBB
JAZZ
BMY
MRK
...
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
3 years ago - By: Benzinga
- Mentions:
SSKN
HOOK
RMED
IBB
...
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
3 years ago - By: UCB, Inc.
UCB Completes Acquisition of Zogenix, Inc.
3 years ago - By: Zogenix, Inc
Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022
3 years ago - By: Zogenix, Inc
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
3 years ago - By: Investor's Business Daily
- Mentions:
MRNA
BNTX
REGN
PFE
...
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
4 years ago - By: WeissLaw LLP
SHAREHOLDER ALERT: WeissLaw LLP Investigates Zogenix, Inc.
4 years ago - By: Invezz
Zogenix up 60% after being acquired by UCB
3 years ago - By: Zogenix, Inc
Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases
4 years ago - By: Investor's Business Daily
- Mentions:
JAZZ
Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest
3 years ago - By: Brodsky & Smith, LLC
- Mentions:
DNAC
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ)
4 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Zogenix, Inc. has obtained a Fair Price in its transaction with UCB.
4 years ago - By: InvestorPlace
- Mentions:
SBEV
KR
DATS
GENI
SBEV Stock: The Ralph’s Grocery Deal Making Waves for Splash Beverage Group Today
4 years ago - By: Halper Sadeh LLP
Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX
4 years ago - By: InvestorPlace
- Mentions:
GENI
SONY
GENI Stock: The Analyst Call Sending Genius Sports Shares Surging Today
4 years ago - By: InvestorPlace
- Mentions:
SONY
SOFI
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
Please enable JavaScript to continue using this application.